Clinical trial
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
NCT00368979 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00368979 |
|---|---|
| Title | Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects |
| Official title | Clinical Evaluation of Dutasteride in Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparative Study of GI198745 (Dutasteride) in Subjects With Benign Prostatic Hyperplasia. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | Dutasteride, Placebo |
| Enrollment | 378 |
| Start date | Feb 17, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 6, 2007 |
| First posted | Aug 29, 2006 |
| Last update posted | Sep 26, 2018 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: